Relying on the above hypothesis, Guo et al. explored the antitumor effect of gemcitabine loaded with human serum albumin nanoparticles (GEM-HSA-NPs) on gemcitabine-resistant pancreatic cancer induced by weak hENT1 expression. This evidence concerns the gene SLC29A1 and familial pancreatic carcinoma.